VistaGen Therapeutics Inc (VTGN)

[Investman432]

The next filing from VSTA will be 8-k to announce 10-k won't be filed on time. Hard to get audit when company has no money to pay accountant.

I am surprised the share price has held, given the vacuum of information on how company is paying its current operating expenses. Loyal shareholders are not willing to cut and run.

If I were Platinum, I'd be hard at work to merge VSTA into another biotech company which has better business/funding capabilities. It's no fun being only deep pocket behind cash sinkhole with no clear time line on producing cash. Especially since the VSTA story has gotten old.

Yes, VSTA raised $50 mm of grants/investment over 15 years -- but where are the commercial products and steady licensing income that should be happening by now? Time has unfortunately shown VSTA doesn't have cutting edge products that are in high demand or offer potential for breakthrough discoveries. All there is is a few ancillary JVs that use stem lines but not assaying IP, and one Phase Ib stage drug of uncertain commercial attraction.

Dribbling in more money behind this management team is folly -- the choice is to sell the IP or merge into another biotech or just close down.